Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped up before the market opened on Friday. The stock had previously closed at $6.42, but opened at $7.1620. Oxford BioMedica shares last traded at $7.1620, with a volume of 180 shares trading hands.
Analysts Set New Price Targets
Separately, Zacks Research raised shares of Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold”.
Check Out Our Latest Report on OXBDF
Oxford BioMedica Trading Up 7.7%
About Oxford BioMedica
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
Further Reading
- Five stocks we like better than Oxford BioMedica
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
- Target’s Holiday Blitz: Slashing Prices to Capture Market Share
- NIO Inc.’s Geely Deal Is Really a Bet on Battery-Swap Network Utilization
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
